B Friedenson

Summary

Publications

  1. ncbi A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision
    B Friedenson
    Department of Biochemistry and Molecular Biology at the University of Illinois at Chicago, Chicago, Illinois, USA
    MedGenMed 3:2. 2001
  2. ncbi Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives
    Bernard Friedenson
    Department of Biochemistry and Molecular Biology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    MedGenMed 4:3. 2002
  3. ncbi Assessing and managing breast cancer risk: clinical tools for advising patients
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, Illinois, USA
    MedGenMed 6:8. 2004
  4. ncbi The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, IL 60607, USA
    BMC Cancer 7:152. 2007
  5. ncbi A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, IL 60607, USA
    Med Hypotheses 77:791-7. 2011
  6. ncbi BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, USA
    MedGenMed 7:60. 2005
  7. ncbi Oral contraceptives and the risk of breast cancer
    Bernard Friedenson
    N Engl J Med 347:1448-9; author reply 1448-9. 2002
  8. ncbi Breast-cancer genomics
    Bernard Friedenson
    N Engl J Med 349:910-1; author reply 910-1. 2003
  9. ncbi Re: BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
    Bernard Friedenson
    J Natl Cancer Inst 96:1184-5; author reply 1185-6. 2004

Detail Information

Publications9

  1. ncbi A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision
    B Friedenson
    Department of Biochemistry and Molecular Biology at the University of Illinois at Chicago, Chicago, Illinois, USA
    MedGenMed 3:2. 2001
    ..In some cases, genetic testing is likely to provide valuable information as she makes choices about contraception and the risks vs. benefits of different alternatives available to her...
  2. ncbi Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives
    Bernard Friedenson
    Department of Biochemistry and Molecular Biology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    MedGenMed 4:3. 2002
  3. ncbi Assessing and managing breast cancer risk: clinical tools for advising patients
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, Illinois, USA
    MedGenMed 6:8. 2004
    ..This paper uses 2 hypothetical but fact-based and typical case histories to discuss the utility of risk assessment tools for informing women about their options...
  4. ncbi The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, IL 60607, USA
    BMC Cancer 7:152. 2007
    ..These kinds of rearrangements are typically associated with some lymphomas and leukemias...
  5. ncbi A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, IL 60607, USA
    Med Hypotheses 77:791-7. 2011
    ..BRCA1/2 mutation carriers may reduce risks for myeloid leukemias by using available precautions to lower their exposure to formaldehyde...
  6. ncbi BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
    Bernard Friedenson
    Department of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, USA
    MedGenMed 7:60. 2005
    ..Identifying molecules that confer growth or survival advantages to BRCA-related cancers may provide broadly useful targets for chemotherapy or chemoprevention...
  7. ncbi Oral contraceptives and the risk of breast cancer
    Bernard Friedenson
    N Engl J Med 347:1448-9; author reply 1448-9. 2002
  8. ncbi Breast-cancer genomics
    Bernard Friedenson
    N Engl J Med 349:910-1; author reply 910-1. 2003
  9. ncbi Re: BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
    Bernard Friedenson
    J Natl Cancer Inst 96:1184-5; author reply 1185-6. 2004